Efficacy and Safety Of Alirocumab to Prevent Early Cardiac Allograft Vasculopathy in Recent Heart Transplant Recipients
Condition: Cardiac Allograft Vasculopathy Interventions: Drug: Alirocumab; Other: Placebo Sponsors: Institute for Clinical and Experimental Medicine; St. Anne's University Hospital Brno, Czech Republic; Centre of Cardiovascular and Transplantation Surgery, Czech Republic Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Bone Graft | Cardiology | Cardiovascular | Cardiovascular & Thoracic Surgery | Czechia Health | Heart | Heart Transplant | Hospitals | Research | Transplant Surgery | Transplants